V. C. Castellón Rubio

Safety of combining dabrafenib plus trametinib in elderly BRAF V600 mutation-positive advanced melanoma patients: real-world data analysis of Spanish patients (ELDERLYMEL)

M. Majem, I. Palacio, C. Aguado, 2022, Melanoma research.

High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score.

J. Lorente, A. Farré, A. Muñoz, 2020, Thrombosis research.

Dabrafenib plus trametinib for compassionate use in metastatic melanoma

A. Arance, V. Soriano, L. Fernández-Morales, 2017, Medicine.